MoveDMD Trial: Catabasis Provides Update (February 2017) The Catabasis team spoke to our community on February 2, 2017 to discuss what they learned from this latest trial and what comes next in the MoveDMD program. Research & Clinical Trial Webinars,Webinars 8 years ago You may also like 1:00:59 Webinar: Advancing DYNE-251 – An Investigational Medicine for Duchenne to Deliver for Patients 3 months ago Research & Clinical Trial Webinars,Webinars dyne therapeutics,DYNE-251 1:05:32 Webinar: Edgewise Therapeutics – Clinical Trials in Becker Muscular Dystrophy 3 months ago Research & Clinical Trial Webinars,Webinars edgewise 58:10 Webinar: Community Progress in Duchenne Newborn Screening 6 months ago Webinars feature,newborn screening 1:01:30 Webinar: Community Update with ITF Therapeutics – Introducing DUVYZAT™ (givinostat) 8 months ago Research & Clinical Trial Webinars,Webinars duvyzat,feature,givinostat,itf therapeutics 45:03 Webinar: Sarepta Therapeutics – Data update from MOMENTUM study, SRP-5051 8 months ago Research & Clinical Trial Webinars,Webinars sarepta 39:33 Webinar: NS Pharma – Overview of New Exon Skipping Trials: Brogidirsen and NS-050/NCNP-03 8 months ago Research & Clinical Trial Webinars,Webinars ns pharma 52:15 Overview of WVE-N531 and the FORWARD-53 Clinical Trial with Wave Life Sciences 9 months ago Research & Clinical Trial Webinars,Webinars wave life sciences,WVE-N531 29:09 PTC Therapeutics — EMFLAZA® Landscape in 2024 9 months ago Care Webinars,Webinars emflaza,ptc therapeutics «1234…25»Page 2 of 25
by: Parent Project Muscular Dystrophy
